SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-031486
Filing Date
2020-02-11
Accepted
2020-02-11 17:04:32
Documents
1
Group Members
FORBION III MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d886447dsc13g.htm SC 13G 54228
  Complete submission text file 0001193125-20-031486.txt   55864
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91001 | Film No.: 20597944
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411DC
Business Address C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411DC 31 35 6993000
Forbion Capital Fund III Cooperatief U.A. (Filed by) CIK: 0001747586 (see all company filings)

IRS No.: 981264117 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G